Literature DB >> 21795349

Expression profiling of the intermediate and late stages of poxvirus replication.

Zhilong Yang1, Sara E Reynolds, Craig A Martens, Daniel P Bruno, Stephen F Porcella, Bernard Moss.   

Abstract

The double-stranded DNA genome of vaccinia virus (VACV), the prototype poxvirus, contains approximately 200 open reading frames (ORFs) that are transcribed at early, intermediate, and late stages of infection. Previous high-throughput deep RNA sequencing allowed us to map 118 VACV early genes that are expressed before viral DNA replication and 93 postreplicative genes. However, the intermediate- and late-stage postreplicative genes could not be differentiated. Here, we synchronized infections with a reversible inhibitor of DNA replication and used a VACV mutant that conditionally transcribes late genes to sequence the two classes of mRNAs. In addition, each postreplicative ORF was individually expressed under conditions that distinguished intermediate and late classes. We identified 38 VACV genes that belong to the late class and 53 that belong to the intermediate class, with some of the latter continuing to be expressed late. These data allowed us to prepare a genome-wide early, intermediate, and late transcription map. Inspection of sequences upstream of these ORFs revealed distinctive characteristics of intermediate and late promoters and suggested that some promoters have intermediate and late elements. The intermediate genes encoded many DNA binding/packaging and core-associated proteins in addition to late transcription factors; the late genes encoded many morphogenesis and mature virion membrane proteins, including those involved in entry, in addition to early transcription factors. The top-ranked antigens for CD4(+) T cells and B cells were mainly intermediate rather than late gene products. The differentiation of intermediate and late genes may enhance understanding of poxvirus replication and lead to improvements in expression vectors and recombinant vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795349      PMCID: PMC3196450          DOI: 10.1128/JVI.05446-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing.

Authors:  Zhilong Yang; Daniel P Bruno; Craig A Martens; Stephen F Porcella; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Authors:  Y Xiang; D A Simpson; J Spiegel; A Zhou; R H Silverman; R C Condit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

3.  Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein.

Authors:  Bruce A Knutson; Xu Liu; Jaewook Oh; Steven S Broyles
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 4.  Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.

Authors:  Magdalini Moutaftsi; David C Tscharke; Kerrie Vaughan; David M Koelle; Lawrence Stern; Mauricio Calvo-Calle; Francis Ennis; Masanori Terajima; Gerd Sutter; Shane Crotty; Ingo Drexler; Genoveffa Franchini; Jon W Yewdell; Steven R Head; Janice Blum; Bjoern Peters; Alex Sette
Journal:  Future Microbiol       Date:  2010-02       Impact factor: 3.165

5.  MochiView: versatile software for genome browsing and DNA motif analysis.

Authors:  Oliver R Homann; Alexander D Johnson
Journal:  BMC Biol       Date:  2010-04-21       Impact factor: 7.431

6.  A complex of seven vaccinia virus proteins conserved in all chordopoxviruses is required for the association of membranes and viroplasm to form immature virions.

Authors:  Patricia Szajner; Howard Jaffe; Andrea S Weisberg; Bernard Moss
Journal:  Virology       Date:  2004-12-20       Impact factor: 3.616

7.  Vaccinia virus l1 protein is required for cell entry and membrane fusion.

Authors:  Himani Bisht; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

8.  Bidirectional transcriptional promoters in the vaccinia virus genome.

Authors:  Bruce A Knutson; Michelle Drennan; Xu Liu; Steven S Broyles
Journal:  Virology       Date:  2008-12-07       Impact factor: 3.616

9.  Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes.

Authors:  Erika Assarsson; Jason A Greenbaum; Magnus Sundström; Lana Schaffer; Jennifer A Hammond; Valerie Pasquetto; Carla Oseroff; R Curtis Hendrickson; Elliot J Lefkowitz; David C Tscharke; John Sidney; Howard M Grey; Steven R Head; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-01       Impact factor: 11.205

10.  Preparation of cell cultures and vaccinia virus stocks.

Authors:  P L Earl; N Cooper; L S Wyatt; B Moss; M W Carroll
Journal:  Curr Protoc Mol Biol       Date:  2001-05
View more
  69 in total

1.  Reverse genetics analysis of poxvirus intermediate transcription factors.

Authors:  Robin D Warren; Catherine A Cotter; Bernard Moss
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 2.  Poxvirus DNA replication.

Authors:  Bernard Moss
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

3.  Direct formation of vaccinia virus membranes from the endoplasmic reticulum in the absence of the newly characterized L2-interacting protein A30.5.

Authors:  Liliana Maruri-Avidal; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

4.  Deciphering poxvirus gene expression by RNA sequencing and ribosome profiling.

Authors:  Zhilong Yang; Shuai Cao; Craig A Martens; Stephen F Porcella; Zhi Xie; Ming Ma; Ben Shen; Bernard Moss
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

Review 5.  Enhancing poxvirus vectors vaccine immunogenicity.

Authors:  Juan García-Arriaza; Mariano Esteban
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Probing the virus host interaction in high containment: an approach using pooled short hairpin RNA.

Authors:  Claire Marie Filone; Ken Dower; Glenn S Cowley; Lisa E Hensley; John H Connor
Journal:  Assay Drug Dev Technol       Date:  2015-02-03       Impact factor: 1.738

7.  Simultaneous Quantification of Viral Antigen Expression Kinetics Using Data-Independent (DIA) Mass Spectrometry.

Authors:  Nathan P Croft; Danielle A de Verteuil; Stewart A Smith; Yik Chun Wong; Ralf B Schittenhelm; David C Tscharke; Anthony W Purcell
Journal:  Mol Cell Proteomics       Date:  2015-03-09       Impact factor: 5.911

8.  Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.

Authors:  Zhilong Yang; Liliana Maruri-Avidal; Jerry Sisler; Carey A Stuart; Bernard Moss
Journal:  Virology       Date:  2013-10-03       Impact factor: 3.616

9.  Poxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responses.

Authors:  Shin-Wu Liu; George C Katsafanas; Ruikang Liu; Linda S Wyatt; Bernard Moss
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

Review 10.  Reflections on the early development of poxvirus vectors.

Authors:  Bernard Moss
Journal:  Vaccine       Date:  2013-04-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.